178 related articles for article (PubMed ID: 18589871)
1. Rat prostate tumors express cancer procoagulant, an activator of coagulation factor X.
Kamocka M; Pollard M; Suckow M; Mielicki WP; Rosen ED
Comp Med; 2008 Jun; 58(3):282-6. PubMed ID: 18589871
[TBL] [Abstract][Full Text] [Related]
2. Cancer procoagulant (CP) analysis in human WM 115 malignant melanoma cells in vitro.
Kaplinska K; Rozalski M; Krajewska U; Mielicki WP
Thromb Res; 2009 Jul; 124(3):364-7. PubMed ID: 19419757
[TBL] [Abstract][Full Text] [Related]
3. Cancer procoagulant--CP.
Rucińska M; Gacko M; Skrzydlewski Z
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():110-7. PubMed ID: 9337529
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Screening of Synthetic Fluorogenic Substrates for Detection of Cancer Procoagulant Activity.
Krause J; Frost CL
Protein J; 2018 Apr; 37(2):151-163. PubMed ID: 29411223
[TBL] [Abstract][Full Text] [Related]
5. A factor X-activating cysteine protease from malignant tissue.
Gordon SG; Cross BA
J Clin Invest; 1981 Jun; 67(6):1665-71. PubMed ID: 7016920
[TBL] [Abstract][Full Text] [Related]
6. Factor X-activating activity from Guerin epithelioma.
Mielicki W; Wierzbicki R
Neoplasma; 1988; 35(3):279-84. PubMed ID: 3405336
[TBL] [Abstract][Full Text] [Related]
7. Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation.
Ogiichi T; Hirashima Y; Nakamura S; Endo S; Kurimoto M; Takaku A
J Neurooncol; 2000; 46(1):1-9. PubMed ID: 10896200
[TBL] [Abstract][Full Text] [Related]
8. Effect of divalent ions on the activity of cancer procoagulant.
Mielicki WP; Kozwich DL; Kramer LC; Gordon SG
Arch Biochem Biophys; 1994 Oct; 314(1):165-70. PubMed ID: 7944389
[TBL] [Abstract][Full Text] [Related]
9. Biochemistry of cancer procoagulant.
Mielicki WP
Haemostasis; 2001; 31 Suppl 1():8-10. PubMed ID: 11990487
[TBL] [Abstract][Full Text] [Related]
10. [Cancer procoagulant (CP)].
Szajda SD; Darewicz B; Gorzel M; Zalewska B; Skrzydlewski Z; Kudelski J; Domel T
Przegl Lek; 2005; 62(3):169-72. PubMed ID: 16171148
[TBL] [Abstract][Full Text] [Related]
11. Three-stage chromogenic assay for the analysis of activation properties of factor X by cancer procoagulant.
Mielicki WP; Gordon SG
Blood Coagul Fibrinolysis; 1993 Jun; 4(3):441-6. PubMed ID: 8329571
[TBL] [Abstract][Full Text] [Related]
12. Procoagulant activity may be a marker of the malignant phenotype in experimental prostate cancer.
Adamson AS; Luckert P; Pollard M; Snell ME; Amirkhosravi M; Francis JL
Br J Cancer; 1994 Feb; 69(2):286-90. PubMed ID: 8297726
[TBL] [Abstract][Full Text] [Related]
13. Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by all-trans-retinoic acid.
Falanga A; Consonni R; Marchetti M; Mielicki WP; Rambaldi A; Lanotte M; Gordon SG; Barbui T
Leukemia; 1994 Jan; 8(1):156-9. PubMed ID: 8289480
[TBL] [Abstract][Full Text] [Related]
14. Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics.
Falanga A; Bolognese Dalessandro AP; Casali B; Roncaglioni MC; Donati MB
Int J Cancer; 1987 Jun; 39(6):774-7. PubMed ID: 3294610
[TBL] [Abstract][Full Text] [Related]
15. The proteolytic profile of human cancer procoagulant suggests that it promotes cancer metastasis at the level of activation rather than degradation.
Kee NL; Krause J; Blatch GL; Muramoto K; Sakka K; Sakka M; Naudé RJ; Wagner L; Wolf R; Rahfeld JU; Demuth HU; Mielicki WP; Frost CL
Protein J; 2015 Oct; 34(5):338-48. PubMed ID: 26341972
[TBL] [Abstract][Full Text] [Related]
16. Cancer procoagulant in human tumor cells: evidence from melanoma patients.
Donati MB; Gambacorti-Passerini C; Casali B; Falanga A; Vannotti P; Fossati G; Semeraro N; Gordon SG
Cancer Res; 1986 Dec; 46(12 Pt 1):6471-4. PubMed ID: 3536081
[TBL] [Abstract][Full Text] [Related]
17. Application of cancer procoagulant as an early detection tumor marker.
Kozwich DL; Kramer LC; Mielicki WP; Fotopoulos SS; Gordon SG
Cancer; 1994 Aug; 74(4):1367-76. PubMed ID: 8055461
[TBL] [Abstract][Full Text] [Related]
18. All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells.
Marchetti M; Russo L; Balducci D; Falanga A
Thromb Res; 2011 Oct; 128(4):368-74. PubMed ID: 21458031
[TBL] [Abstract][Full Text] [Related]
19. Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activity.
Donati MB; Falanga A; Consonni R; Alessio MG; Bassan R; Buelli M; Borin L; Catani L; Pogliani E; Gugliotta L
Thromb Haemost; 1990 Aug; 64(1):11-6. PubMed ID: 2274915
[TBL] [Abstract][Full Text] [Related]
20. Properties of proteins in cancer procoagulant preparations that are detected by anti-tissue factor antibodies.
Raasi S; Mielicki WP; Gordon SG; Korte W
Arch Biochem Biophys; 2004 Aug; 428(2):131-5. PubMed ID: 15246868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
